Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Chambers Michael Andrew
Director at Sarepta Therapeutics. Filing since 19 Aug 2022.
CIK 0001932527
Company
Date
Role
Action
Shares
Amount
Of holding
SRPT
Sarepta Therapeutics, Inc.
16 Aug 2024
Director
Bought
37,038
$4.96M
15.0%
SRPT
Sarepta Therapeutics, Inc.
14 Aug 2023
Director
Bought
9,979
$1.09M
4.2%
SRPT
Sarepta Therapeutics, Inc.
11 Aug 2023
Director
Bought
23,686
$2.56M
11.1%
SRPT
Sarepta Therapeutics, Inc.
10 Aug 2023
Director
Bought
34,867
$3.70M
19.5%
SRPT
Sarepta Therapeutics, Inc.
14 Sep 2022
Director
Bought
57,100
$5.96M
112%
SRPT
Sarepta Therapeutics, Inc.
19 Aug 2022
Director
Bought
46,170
$5.00M
941%
6 decisions on file.
